Aviron finds deep Korean pockets

As companies search for sources of financing that allow them to do more than merely survive, kudos go to those that can come up with untapped, deep pockets partners. Aviron has done just that, announcing a collaboration with Sang-A, a Korean pharmaceutical company and member of the Hanbo Group conglomerate.

Sang-A will make an equity investment for 10 percent to 25 percent of Aviron, and the Korean company will participate in future financings.

Read the full 727 word article

How to gain access

Continue reading with a
two-week free trial.